S pravočasnim ukrepanjem lahko upočasnimo napredovanje kronične ledvične bolezni, zmanjšamo tveganje za razvoj bolezni srca in ožilja ter podaljšamo čas do dialize.3,4


Reference:
1. National Institute of Diabetes and Digestive and Kidney Diseases. Chronic Kidney Disease (CKD). Dostopno na: https://www.niddk.nih.gov/health-information/kidney-disease/chronic-kidney-disease-ckd (Dostopano 24.3.2025).
2. Ravera M, et al. CKD awareness and blood pressure control in the primary care hypertensive population. Am J Kidney Dis. 2011;57(1):71-77 in Thu H et al. Clin Nephrol. 2018;89(3):205-213.
3. International society of nephrology (ISN). Dostopno na: https://www.theisn.org/ (Dostopano 24.3.2025).
4. Kdigo. CKD Evaluation and Management. Dostopno na: https://kdigo.org/guidelines/ckd-evaluation-and-management/ (Dostopano 24.3.2025).
5. Centers for disease control and prevention (CDC). Chronic Kidney Disease Basics. Dostopno na: https://www.cdc.gov/kidneydisease/basics.html (Dostopano 24.3.2025).
Datum priprave: marec 2025
AstraZeneca UK Limited, Podružnica v Sloveniji, Verovškova 55, Ljubljana, tel.: 01/ 51 35 600
SI-4977